Type 2 Diabetes

  1. Home
  2. Health
  3. Type 2 Diabetes
photo of Debra Manzella, R.N.

Type 2 Diabetes Blog

By Debra Manzella, R.N., About.com Guide to Type 2 Diabetes

Exubera Label Now Includes Warning for Lung Cancer

Thursday May 1, 2008
A press release from Pfizer, dated April 9, 2008, states that product labeling for Exubera, the company's inhaled insulin, has been changed to include a warning that lung cancer cases have been observed in patients who have used Exubera.

A clincial trial that involved 4,740 people who used Exubera and 4,292 people who did not, showed that 6 of the Exubera group developed lung cancer, versus only 1 person in the group who did not use the drug.

Pfizer does say that all of the people who were diagnosed with lung cancer had also been smokers, and that the study was too small to say for sure that the lung cancer was caused by Exubera.

Pfizer actually stopped marketing Exubera in October of 2007, because sales did not meet expectations. However there are still people who use Exubera, such as people who are in extended transition programs or clinical trials.

Pfizer recommends that people who are still using Exubera should talk to their doctors about other options to treat their diabetes.

Photo courtesy of Medioimages/Photodisc/Getty Images

Comments

No comments yet. Leave a Comment

Leave a Comment

Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>

Discuss

Community Forum

Explore Type 2 Diabetes

About.com Special Features

Do I Have Allergies?

Are your symptoms merely irritating, or could they be a sign of allergies? More >

Preventing Headaches

The best way to treat a headache is to prevent it. Learn how. More >

Type 2 Diabetes

  1. Home
  2. Health
  3. Type 2 Diabetes

©2009 About.com, a part of The New York Times Company.

All rights reserved.